Vidodfludimus Calcium Uniquely Combines Direct Neuroprotective & Anti-inflammatory Properties for the Treatment of Multiple Sclerosis

• Combining neuroprotection and relapse prevention by targeting the neuroprotective factor Nurr1 and anti-inflammatory target DHODH
• Addressing neuronal function as a potential therapy for both relapsing and progressive forms of neurodegenerative diseases 
• Investigating Nurr1 as a relevant target to treat different neurodegenerative diseases

Speakers:

Hella Kohlhof

Chief Scientific Officer

Immunic Therapeutics